Skip to content

Women's Health in Youth with a Chronic Condition

Female Reproductive Health in Adolescents With a Chronic Condition - Female Reproductive Health in Adolescents With a Chronic Disease (FLOW Study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58563
Enrollment
600
Registered
2025-10-08
Start date
2026-08-03
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female reproductive health, menstrual health, fertility female health, period, reproduction

Interventions

This is an observational, cross-sectional study without an intervention. Study procedures include the collection of patient-reported menstrual health outcomes through questionnaires and the assessment

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
12 Years to 64 Years

Inclusion criteria

Inclusion criteria: The subject is included in the PROactive or WHISTLER cohort and has given consent to be approached for future research purposes. The subject is of the female sex.The subject is aged =12 years old and <25 years old at the time of inclusion.

Exclusion criteria

Exclusion criteria: Known chromosomal or genetic syndromes directly affecting gonadal function (e.g., Turner syndrome, Klinefelter syndrome, disorders of sex development).Current pregnancy.Prior gonadotoxic treatment unrelated to the chronic condition under study (e.g., chemotherapy or radiotherapy for malignancy outside the context of the disease groups included in PROactive).

Design outcomes

Primary

MeasureTime frame
The main study parameter is menstrual health, evaluated through patient-reported outcomes including age at menarche, cycle regularity, presence and severity of dysmenorrhea, menstrual blood loss, influence of menstrual symptoms on psychological wellbeing and daily life, and contraceptive use.

Secondary

MeasureTime frame
The secondary objectives address ovarian reserve, assessed through serum AMH levels obtained via venous blood sampling. 

Countries

Netherlands

Contacts

Public ContactD.E. Bruil

Universitair Medisch Centrum Utrecht

d.e.bruil@umcutrecht.nl+31 6 50 17 78 30

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 25, 2026